Clinical Trials Directory

Trials / Unknown

UnknownNCT04336423

Analysis of the Microbiome in the Healthy Smokers and COPD Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is to build a microbiome cohort by collecting sputum and fecal samples every few months for three years from healthy smokers and chronic obstructive pulmonary disease (COPD) patients. The aim of this study is to analyze the composition of microbiome of various samples (e.g. sputum, feces) and describe the difference between healthy smokers and COPD patients.

Detailed description

After the introduction of the gut-lung axis theory, extensive studies revealed the diversity of microbiomes among healthy smokers and COPD patients form the respiratory samples or lung tissues. In the previous study, distinct difference in composition of microbiome in lung tissue between healthy smokers and COPD patients was reported. This study is to build a microbiome cohort by collecting sputum and fecal samples every few months for three years from healthy smokers and chronic obstructive pulmonary disease (COPD) patients who are being followed up by Asan Medical Center. The aim of this study is to analyze the composition of microbiome of various samples (e.g. sputum, feces) and describe the difference between healthy smokers and COPD patients. This study would help establishing gut-lung axis model in humans.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTObtain samples from sputum and fecesSamples are obtained from participants. No further intervention is required. Obtained samples will be further analyzed.

Timeline

Start date
2020-04-06
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2020-04-07
Last updated
2020-04-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04336423. Inclusion in this directory is not an endorsement.